Cargando…

Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications

BACKGROUND: The National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines (TCMs) with the adoption of regulatory science (RS). However, the priority of actions at the interface of RS and TCMs were yet to be defined. This rese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zuanji, Lai, Yunfeng, Li, Meng, Shi, Junnan, Lei, Chi Ieong, Hu, Hao, Ung, Carolina Oi Lam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884970/ https://www.ncbi.nlm.nih.gov/pubmed/33593397 http://dx.doi.org/10.1186/s13020-021-00433-2

Ejemplares similares

Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities
por: Shi, Junnan, et al.
Publicado: (2023)

Advancing the Regulation of Traditional and Complementary Medicine Products: A Comparison of Five Regulatory Systems on Traditional Medicines with a Long History of Use
por: Liang, Zuanji, et al.
Publicado: (2021)

Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model
por: Li, Meng, et al.
Publicado: (2021)

Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials
por: Liang, Zuanji, et al.
Publicado: (2021)

An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review
por: Shi, Junnan, et al.
Publicado: (2019)

Involving systems thinking and implementation science in pharmacists’ emerging role to facilitate the safe and appropriate use of traditional and complementary medicines
por: Harnett, Joanna E., et al.
Publicado: (2020)

Policy Interventions, Development Trends, and Service Innovations of Internet Hospitals in China: Documentary Analysis and Qualitative Interview Study
por: Lai, Yunfeng, et al.
Publicado: (2021)

Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design
por: Chen, Xianwen, et al.
Publicado: (2023)

Internationalization of Traditional/Complementary Medicine products: market entry as medicine
por: Li, Jiatong, et al.
Publicado: (2018)

Advancing UK regulatory science and innovation in healthcare
por: Calvert, Melanie J, et al.
Publicado: (2020)

Regulatory science: The need for empowering Indian innovation
por: Dinda, Amit Kumar
Publicado: (2021)

Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials
por: Li, Yuxiao, et al.
Publicado: (2023)

Communicating to and engaging with the public in regulatory science
por: Smith, Anthony, et al.
Publicado: (2019)

Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials
por: Yang, Jingya, et al.
Publicado: (2023)

New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science
por: Chiu, Kimberly, et al.
Publicado: (2023)

Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak
por: Ung, Carolina Oi Lam
Publicado: (2020)

Predicting Pharmacist Intention to Contribute to COVID-19 Management at the Community Level: A Cross-Sectional Survey Study
por: Li, Junlei, et al.
Publicado: (2021)

Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications
por: Zou, Kelly H, et al.
Publicado: (2020)

Perspective on--public information, science, and the regulatory process.
por: Burger, E J
Publicado: (1972)

Advancing Regulatory Science Through Innovation: In Vitro Microphysiological Systems
por: Fitzpatrick, Suzanne, et al.
Publicado: (2018)

Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation
por: Lee, Myrto, et al.
Publicado: (2019)

Exploring the implementation of an outreach specialist program for nursing home residents in Macao: A multisite, qualitative study
por: Cen, Zhifeng, et al.
Publicado: (2022)

Patterns in the Public Square: Reference Models for Regulatory Science
por: Schindel, William D.
Publicado: (2022)

Obstacles and opportunities in Chinese pharmaceutical innovation
por: Ni, Jingyun, et al.
Publicado: (2017)

Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis
por: Yan, Xin, et al.
Publicado: (2022)

Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research
por: Xue, Yan, et al.
Publicado: (2023)

Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives
por: Yao, Dongning, et al.
Publicado: (2020)

Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities
por: Ingram, Beverly, et al.
Publicado: (2021)

Towards consensus: defining and supporting a professional role for pharmacists associated with traditional and complementary medicines – a protocol of implementing an international e-survey
por: Harnett, Joanna E, et al.
Publicado: (2022)

Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science
por: Rouse, Rodney, et al.
Publicado: (2017)

Advancing regulatory science, advancing regulatory practice
por: Kurz, Xavier
Publicado: (2017)

Regulatory Science Needs for Neonates: A Call for Neonatal Community Collaboration and Innovation
por: McCune, Susan K., et al.
Publicado: (2014)

Building an innovation system of medical devices in China: Drivers, barriers, and strategies for sustainability
por: Cheong, Sok Teng, et al.
Publicado: (2020)

Trends and Development in Enteral Nutrition Application for Ventilator Associated Pneumonia: A Scientometric Research Study (1996–2018)
por: Chen, Shengqi, et al.
Publicado: (2019)

Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
por: Luo, Zejun, et al.
Publicado: (2021)

Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis
por: Zou, Huimin, et al.
Publicado: (2022)

Exploration of facilitators and barriers to the regulatory frameworks of dietary and herbal supplements: a scoping review
por: Ng, Jeremy Y., et al.
Publicado: (2022)

The Role of Regulatory Sciences from the Perspective of the Cuban Medicines Regulatory Agency: The Impact of COVID-19 in Promoting Innovation, Cooperation and Scientific Thinking
por: Romeu, Belkis, et al.
Publicado: (2021)

3523 Innovative Approaches to Clinical Research on Placebo Effects: A Regulatory Science Perspective
por: Uweh, Kimberly
Publicado: (2019)

Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed model
por: Hines, Philip A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o9nffhlprb3ihrt823tocrb7il